Skip to main content
. 2022 Apr 14;54(5):102302. doi: 10.1016/j.aprim.2022.102302

Table 4.

OR for poor Type 2 Diabetes Mellitus control based on the characteristics of the sample for each sex and global.

Men
Women
Global
OR 95%CI P value OR 95%CI P value OR 95%CI P value
Sex (men)
 Women 1.09 0.82–1.45 0.549



Age group (66–79)
 80–84 1.31 0.72–2.38 0.383 1.01 0.62–1.65 0.958 1.13 0.77–1.64 0.540
 85 y más 1.27 0.71–2.27 0.422 1.08 0.69–1.68 0.740 1.16 0.82–1.65 0.398



Social risk (no)
 Yes 1.07 0.59–1.93 0.821 0.77 0.54–1.11 0.163 0.86 0.63–1.16 0.328



Deprivation Index Quartile (Group 4)
 Group 1 1.06 0.60–1.87 0.853 0.91 0.58–1.42 0.666 1.24 0.76–2.03 0.386
 Group 2 1.28 0.67–2.44 0.452 0.82 0.51–1.33 0.424 1.20 0.76–1.90 0.439
 Group 3 0.80 0.31–2.04 0.641 0.76 0.43–1.37 0.366 1.20 0.74–1.96 0.456



Body mass index (low weight/normal weight)
 Overweight 1.86 0.88–3.89 0.102 1.51 0.86–2.65 0.146 1.59 1.02–2.48 0.039
 Obesity 2.63 1.21–5.73 0.015 1.35 0.78–2.34 0.290 1.71 1.09–2.67 0.020



Physical activity (yes)
 No 1.97 1.03–3.78 0.040 0.72 0.48–1.08 0.114 0.95 0.68–1.33 0.776



Time with diabetes (10 years)
 11–15 years 2.07 1.21–3.55 0.008 2.61 1.74–3.93 0.000 2.40 1.74–3.33 0.000
 >15 years 2.69 1.41–5.12 0.003 2.57 1.63–4.06 0.000 2.60 1.80–3.77 0.000



Depression/anxiety symptoms (no)
 Yes 0.99 0.54–1.81 0.975 0.83 0.57–1.22 0.345 0.89 0.65–1.22 0.458



Non-adherence to pharmacological treatment (no)
 Yes 4.68 1.60–13.65 0.005 0.76 0.30–1.88 0.548 1.64 0.86–3.12 0.132

The reference category of each variable is shown in parentheses; 95% CI: 95 confidence intervals.